semaglutide or tirzepatide for weight loss Semaglutide/Tirzepatide: Beyond Loss: Shamsah Amersi, MD: OB-GYNs Troubling Findings in Study of

The SURMOUNT trial program provides extensive data on what tirzepatide achieves without any additional weight loss medication: 5 mg dose: 15.0% average weight loss at 72 weeks 10 mg dose: 19.5% average weight loss at 72 weeks 15 mg dose: 20.9% average weight loss at 72 weeks At 15 mg, 56.1% of participants lost at least 20% of body weight At 15 mg, 38.7% of participants lost at least 25% of body weight These numbers are remarkable

Philadelphia: Saunders

Ha inkbb ltalnos vitalitsfokozs a cl, kisebb adagokban, tkezs kzben is fogyaszthat

This is an effective SHP independent pathway to inhibit CYP7A1 [51, 55, 62]

10.1016/S0165-1781(00)00176-1 Psychiatry Res